POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare

Markets PR Newswire By PR Newswire 12 Oct 2026 12:00 1 min read
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare

GUANGZHOU, China, Oct. 12, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing artificial intelligence ("AI")-enabled healthcare solutions, today highlighted its strategy to participate in the ongoing...

Covered in this story

Call it yourself

No calls on $POM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Pomdoctor →
Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.